The analysis of p62 expression in patients with TCGA‐LGG revealed that heightened p62 expression is associated with reduced overall survival (Figure 3E), higher glioma grades (Figure 3F), and increased prevalence in IDH wild‐type status (Figure 3G). The gene discussed is IGF2BP2; the disease is central nervous system cancer.